Idexx Laboratories's total assets for Q3 2025 were $3.39B, an increase of 1.68% from the previous quarter. CH:IX1 total liabilities were $573.72M for the fiscal quarter, a -69.35% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.